Table 15.
Summary of the contribution of each of the studies (summarised in Tables 11–14) to each of the remarks
| No.a | Studies supporting the conclusion | Microbial organisms (isolated from calf faeces), antimicrobials (AMs) and/or resistance mechanisms investigated |
|---|---|---|
| 1 | Dolejská et al. (2008) | Escherichia coli; 12 AMs |
| Kyselková et al. (2015) | tet (tetracycline resistance) genes by PCR | |
| Duse et al. (2015) | E. coli; 12 AMs | |
| Brunton et al. (2014) | E. coli; cefquinome | |
| Aust et al. (2013) | E. coli; 25 AMs | |
| Langford et al. (2003) | Bacteria; penicillin | |
| Pereira et al. (2014) | E. coli; ceftofur, penicillin, ampicillin, oxytetracycline | |
| Berge et al. (2006) | E. coli; tetracycline hydrochloride, neomycin sulfate | |
| 2 | Aust et al. (2013) | E. coli; 25 AMs |
| 3 | Aust et al. (2013) | Enterococcus faecalis; 25 AMs |
| 4 | Duse et al. (2015) | E. coli; penicillin and aminoglycosides |
| 5 | Gonggrijp et al. (2015) | E. coli; ESBL/AmpC‐encoding genes |
| 6 | Kyselková et al. (2015) | tet (tetracycline resistance) genes by PCR |
| Randall et al. (2014) | E. coli; AMs and CTX‐M encoding genes | |
| Brunton et al. (2014) | E. coli; cefquinome | |
| Aust et al. (2013) | E. coli; 25 AMs | |
| Pereira et al. (2014) | E. coli; ceftofur, penicillin, ampicillin, oxytetracycline | |
| Alali et al. (2004) | E. coli O157:H7; nalidixic acid resistant | |
| 7 | Brunton et al. (2014) | E. coli; cefquinome |
| 8 | Duse et al. (2015) | E. coli; 12 AMs |
| Berge et al. (2006) | E. coli; tetracycline hydrochloride, neomycin sulfate | |
| 9 | Duse et al., 2015; | E. coli; 12 AMs |
| 10 | Langford et al. (2003) | Bacteria; penicillin resistance |
| Pereira et al. (2014) | E. coli; ceftofur, penicillin, ampicillin, oxytetracycline | |
| Berge et al. (2006) | E. coli; tetracycline hydrochloride, neomycin sulfate |
PCR: polymerase chain reaction.
The numbers relate to the numbered summary remarks.